Thursday's pre-bell tape brings the usual contrast between enterprise reality and micro-cap fantasy.
$OKTA rips 18.29% after posting actual Q2 fiscal earnings, while $PPCB launches 297.20% on preclinical mouse data for a company with a $3M market cap. On the other side of the tape, $CHGA drops 21.78% after dropping a 1-for-20 reverse stock split on its bagholders.
Here is the math retail ignores: across 2,881 historical catalyst gaps of 30% or more, the stock closes red 65% of the time, bleeding a median -6.79% intraday.
Are you chasing early hype, or waiting for the base rate to collect its toll?